E-ISSN 2231-3206 | ISSN 2320-4672
 
2024, Vol: 14, Issue: 10
14 / 10Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles
Required files to be uploaded

Authorship Declaration

Case Series
Online Published: 02 Apr 2024
 


Bullous pemphigoid associated with the use of DPP4 inhibitors: A case series

Manali Saha, Mriganka Bandyopadhyay, Ananya Mandal, Arijit Ghosh, Pragnadyuti Mandal, Suman Chattopadhyay.


Abstract
Dipeptidyl-peptidase 4 (DPP-4) inhibitors are one of the most commonly used anti-diabetic drugs because of their established safety and efficacy. Bullous pemphigoid which is an autoimmune blister skin disorder associated with DPP-4 inhibitors is a recognized adverse drug reaction (ADR) reported in some Southeast Asian Nations but has not been reported earlier from India. It is an uncommon, serious treatment with emergent adverse effects. Here, we report a series of five cases of DPP-4 inhibitor Linagliptin-induced bullous pemphigoid reaction in Type 2 diabetes mellitus patients. We are reporting five cases that showed various clinical manifestations in terms of gender (males 4), duration of diabetes (average 7.2 years), glycemic control (average HbA1C 6.7%), and latency period (average 3.6 weeks) for development of the ADR. Quality of life and treatment satisfaction were severely impacted by this ADR. Withdrawal of Linagliptin, use of topical and oral steroids and immunosuppressant like azathioprine were prescribed and effective for improving the lesions of all the cases. As per the World Health Organization-Uppsala Monitoring Center scale, causality was established as “probable” for all the cases. This case series serves to bring to the notice of prescribers regarding this important cutaneous ADR with the use of Linagliptin. This case intends to improve awareness among clinicians regarding the possibility of this cutaneous ADR among diabetic patients to facilitate early diagnosis and intervention.

Key words: Bullous Pemphigoid; Linagliptin; Teneligliptin; DPP4 Inhibitors; Diabetes Mellitus; Adverse Drug Reaction; Pharmacovigilance


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Manali Saha
Articles by Mriganka Bandyopadhyay
Articles by Ananya Mandal
Articles by Arijit Ghosh
Articles by Pragnadyuti Mandal
Articles by Suman Chattopadhyay
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Saha M, Bandyopadhyay M, Mandal A, Ghosh A, Mandal P, Chattopadhyay S. Bullous pemphigoid associated with the use of DPP4 inhibitors: A case series. Natl J Physiol Pharm Pharmacol. 2024; 14(9): 2012-2016. doi:10.5455/njppp.2024.14.12587202316032024

Web Style

Saha M, Bandyopadhyay M, Mandal A, Ghosh A, Mandal P, Chattopadhyay S. Bullous pemphigoid associated with the use of DPP4 inhibitors: A case series. https://www.njppp.com/?mno=183062 [Access: October 05, 2024]. doi:10.5455/njppp.2024.14.12587202316032024

AMA (American Medical Association) Style

Saha M, Bandyopadhyay M, Mandal A, Ghosh A, Mandal P, Chattopadhyay S. Bullous pemphigoid associated with the use of DPP4 inhibitors: A case series. Natl J Physiol Pharm Pharmacol. 2024; 14(9): 2012-2016. doi:10.5455/njppp.2024.14.12587202316032024


Vancouver/ICMJE Style

Saha M, Bandyopadhyay M, Mandal A, Ghosh A, Mandal P, Chattopadhyay S. Bullous pemphigoid associated with the use of DPP4 inhibitors: A case series. Natl J Physiol Pharm Pharmacol. (2024), [cited October 05, 2024]; 14(9): 2012-2016. doi:10.5455/njppp.2024.14.12587202316032024


Harvard Style

Saha, M., Bandyopadhyay, . M., Mandal, . A., Ghosh, . A., Mandal, . P. & Chattopadhyay, . S. (2024) Bullous pemphigoid associated with the use of DPP4 inhibitors: A case series. Natl J Physiol Pharm Pharmacol, 14 (9), 2012-2016. doi:10.5455/njppp.2024.14.12587202316032024


Turabian Style

Saha, Manali, Mriganka Bandyopadhyay, Ananya Mandal, Arijit Ghosh, Pragnadyuti Mandal, and Suman Chattopadhyay. 2024. Bullous pemphigoid associated with the use of DPP4 inhibitors: A case series. National Journal of Physiology, Pharmacy and Pharmacology, 14 (9), 2012-2016. doi:10.5455/njppp.2024.14.12587202316032024


Chicago Style

Saha, Manali, Mriganka Bandyopadhyay, Ananya Mandal, Arijit Ghosh, Pragnadyuti Mandal, and Suman Chattopadhyay. "Bullous pemphigoid associated with the use of DPP4 inhibitors: A case series." National Journal of Physiology, Pharmacy and Pharmacology 14 (2024), 2012-2016. doi:10.5455/njppp.2024.14.12587202316032024


MLA (The Modern Language Association) Style

Saha, Manali, Mriganka Bandyopadhyay, Ananya Mandal, Arijit Ghosh, Pragnadyuti Mandal, and Suman Chattopadhyay. "Bullous pemphigoid associated with the use of DPP4 inhibitors: A case series." National Journal of Physiology, Pharmacy and Pharmacology 14.9 (2024), 2012-2016. Print. doi:10.5455/njppp.2024.14.12587202316032024


APA (American Psychological Association) Style

Saha, M., Bandyopadhyay, . M., Mandal, . A., Ghosh, . A., Mandal, . P. & Chattopadhyay, . S. (2024) Bullous pemphigoid associated with the use of DPP4 inhibitors: A case series. National Journal of Physiology, Pharmacy and Pharmacology, 14 (9), 2012-2016. doi:10.5455/njppp.2024.14.12587202316032024




Most Viewed Articles
Most Accessed Articles

  • Applications of computer science in Pharmacy: An overview
    Shivraj Popat Jadhav, Komal Nikam, Anand Gandhi, Kishor Salunkhe, Narendra Shinde.
    Natl J Physiol Pharm Pharmacol. 2012; 2(1): 1-9
    » Abstract

  • How to calculate sample size in animal studies?
    Hitesh Shah
    Natl J Physiol Pharm Pharmacol. 2011; 1(1): 35-39
    » Abstract

  • Chlorhexidine:The gold standard in chemical plaque control [English]
    Setu mathur, Tanu mathur,Rahul shrivastava, Rohit khatri
    Natl J Physiol Pharm Pharmacol. 2011; 1(2): 45-50
    » Abstract

  • Assessment of Nutritional Status of Pregnant Women Attending the City Tebessa PMI (Algeria) [English]
    Taleb Salima, Kaibi Mounira, Deghboudj Nadjia
    Natl J Physiol Pharm Pharmacol. 2011; 1(2): 97-105
    » Abstract

  • Difference in pulmonary function test among the athletic and sedentary population
    ShobhaRani Vedala, Niranjan Paul, Abhay B Mane
    Natl J Physiol Pharm Pharmacol. 2013; 3(2): 118-123
    » Abstract » doi: 10.5455/njppp.2013.3.109-114

    •
    Most Downloaded
    Top Downloaded Articles

  • How to calculate sample size in animal studies?
    Hitesh Shah
    Natl J Physiol Pharm Pharmacol. 2011; 1(1): 35-39
    » Abstract

  • Applications of computer science in Pharmacy: An overview
    Shivraj Popat Jadhav, Komal Nikam, Anand Gandhi, Kishor Salunkhe, Narendra Shinde.
    Natl J Physiol Pharm Pharmacol. 2012; 2(1): 1-9
    » Abstract

  • Evaluation of potential drug-drug interaction in indoor patients of pediatric department of tertiary care hospital
    Simran Patel, Mayur Chaudhari, Nrupal Patel
    Natl J Physiol Pharm Pharmacol. 2019; 9(10): 1012-1016
    » Abstract » doi: 10.5455/njppp.2019.9.0725209072019

  • Chlorhexidine:The gold standard in chemical plaque control [English]
    Setu mathur, Tanu mathur,Rahul shrivastava, Rohit khatri
    Natl J Physiol Pharm Pharmacol. 2011; 1(2): 45-50
    » Abstract

  • Analyzing Pharmaceutical Industry [English]
    Veselin Tima Dickov, Dragan Mitrovic, Boris Milan Kuzman
    Natl J Physiol Pharm Pharmacol. 2011; 1(1): 1-8
    » Abstract » doi: 10.5455/njppp.2011.1.1-8

    •
    Most Cited Articles
    Most Cited Articles

    About National Journal of Physiology, Pharmacy and Pharmacology

      National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal.  The journal is having open access polic ... Read more.



    For best results, please use Internet Explorer or Google Chrome.

    Contact Information

    Eldaghayes Publisher

    www.eldagpublisher.com 

     
    All correspondence should be addressed to:
    Prof. Ibrahim Eldaghayes
    Editor-in-Chief
    National Journal of Physiology, Pharmacy and Pharmacology
    Email: ibrahim.eldaghayes@vetmed.edu.ly
    POLICIES & JOURNAL LINKS
    Author Login
    Reviewer Login
    About Publisher
    Advertising Policy
    Author's Rights and Obligations
    Conflict of Interest Policy
    Copyright Information
    Digital Archiving & Preservation Policies
    Editorial Policies
    Peer Review Policy
    Editorial & Peer Review Process
    License Information
    Open Access Policy
    Plagiarism Policy
    Privacy Policy
    Protection of Research Participants (Statement On Human And Animal Rights)
    Publication Ethics and Publication Malpractice Statement
    Corrections, Retractions & Expressions of Concern
    Self-Archiving Policies
    Statement of Informed Consent
    Terms of Use